Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Mayo Clinic researchers restore lost immunity -- Possible breakthrough for AIDS

20.04.2004


Mayo Clinic researchers have found a way to revive immunity in mice that have abnormal or deficient immune systems. The discovery may lead to a means of restoring immunity to individuals with immunodeficiency diseases such as AIDS and cancer. Also, because the research involves an existing therapy, application may be possible in the near future.



The research team, led by Mayo Clinic immunologists Marilia Cascalho, M.D., Ph.D., and Jeffrey Platt, M.D., report in this month’s Journal of Immunology that B cells, the lymphocytes that produce antibodies, help to generate T cells, the lymphocytes that fight viruses and tumors.

"Previously, it was thought that B cells and T cells, two components of immunity produced by the lymphatic tissues, develop independently until they eventually came together to fight microbes or to eliminate infected cells in the body," says Dr. Cascalho. "Now we know that the B cells and the immunoglobulin that they produce can help reconstitute immunity by promoting the development of T cells." For immunity to work it is crucial that there are enough T cells and also that the T cells be diverse so they are able to respond to many different threats. B cells help to make the T cells in the body diverse. Immunoglobulin is a specialized protein that acts as an antibody.


Diversity of lymphocyte receptors is thought to be the key to immunity. A cell’s receptor is the portion that makes it selectively bind with another substance. The more diverse T cell receptors are, the more likely it is T cells of the appropriate specificity will be present to combat today’s sophisticated viruses or evasive bacteria. This flexibility and corresponding T cell receptor diversity are absent in patients with immunodeficiency diseases and in some who have cancer or receive cancer treatment. AIDS patients, for example, may have very few T cells and those T cells they have may not be diverse. The report by Dr. Cascalho’s group suggests it may be possible to boost T cell numbers and diversity by administration of gamma globulin or B cells. Gamma globulin is a protein portion of blood rich in antibodies that is made from pooled human blood and injected as one form of immunotherapy.

"By understanding how the body produces T cell diversity in this way, we believe it may have direct impact on many patients whose immune defenses have been compromised," says Dr. Platt. "There was no way we knew of that this part of the immune system could build itself back up. Now, we think that this is a way." Whether B cells contribute to a diversity of T cells through means other than immunoglobulin isn’t known.

A Second Possible Approach

Dr. Cascalho theorizes that the gamma globulin might also counter autoimmunity. In some cases autoimmune diseases, such as arthritis, arise because the body lacks the diverse T cells needed to control immune responses. She says gamma globulin could promote the production of new T cells which can control the overreacting T cells that attack the body’s healthy cells. In this way, clinicians may be able to alter immunity by skewing or redirecting the focus of the body’s misdirected immune response. While she says this theory is untested, it could be one more method for controlling autoimmunity.

Accelerated Human Trials

The next step is to test the current findings in clinical trials. This process may take less time than usual because gamma globulin is approved by the U.S. Food and Drug Administration for other uses. That will allow the researchers to retarget it to verify their discovery in humans.

"Because of this availability, we should expect to see some results in a matter of a few years, rather than in a decade or more," says Dr. Cascalho.

The researchers want to discover whether all or only part of the immunoglobulin molecule is essential to "jump start" T cell production. If they can identify the critical portion of the molecule, it might be manufactured at less cost than the expensive fully-constituted human immunoglobulin. In addition to the AIDS virus, immune deficiency can be caused by a range of autoimmune diseases, old age, and can be a result of chemotherapy treatments for cancer.

Study Details

Researchers transferred B cells or gamma globulin from normal mice to those with limited T cell diversity and found that the thymus generated new T cells with increased diversity. However, administration of monoclonal B cells or monoclonal immunoglobulin did not result in production of more diverse T cells, proving that diverse B cells and or immunoglobulin were essential to restore immunity.


The lead author of the research article, predoctoral student Cristina Joao, worked with Dr. Cascalho, who heads the laboratory, and Dr. Platt, who heads the research program in which the work was carried out. Others involved in the study included Brenda M. Ogle, Ph.D., and Carlota Gay-Rabinstein, M.D.

[Cristina João, Brenda M. Ogle, Carlota Gay-Rabinstein, Jeffrey L. Platt, and Marilia Cascalho. (2004). B cell-dependent TCR diversification. J. Immunology 172: 4709 – 4716.]

Bob Nellis | EurekAlert!
Further information:
http://mayo.edu/

More articles from Health and Medicine:

nachricht Tracking movement of immune cells identifies key first steps in inflammatory arthritis
23.01.2017 | Massachusetts General Hospital

nachricht Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Quantum optical sensor for the first time tested in space – with a laser system from Berlin

For the first time ever, a cloud of ultra-cold atoms has been successfully created in space on board of a sounding rocket. The MAIUS mission demonstrates that quantum optical sensors can be operated even in harsh environments like space – a prerequi-site for finding answers to the most challenging questions of fundamental physics and an important innovation driver for everyday applications.

According to Albert Einstein's Equivalence Principle, all bodies are accelerated at the same rate by the Earth's gravity, regardless of their properties. This...

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Arctic melt ponds form when meltwater clogs ice pores

24.01.2017 | Earth Sciences

Synthetic nanoparticles achieve the complexity of protein molecules

24.01.2017 | Life Sciences

PPPL physicist uncovers clues to mechanism behind magnetic reconnection

24.01.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>